Hey dd- appreciate your insightful communication- obviously you have some experience in due diligence corporate functions, and you speak with clarity - regarding the bayer patents would you have any guess to the transaction value and how qmc would have financed the purchase if there is no continued royalties? It would seem they would be expensive patents outright if so.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.